Smartstockz

[december]

My new big pick is HBSC



I am really excited about HBSC because they are developing a technology that could save millions of lives!! HBSC could definitely be the next biotech giant.

The Biotech industry in particular is one that has made many people filthy rich. Imagine if you had invested in Amgen from the beginning, $1000 would have returned well over $1 million dollars.

HBSC has developed and is gearing up to market their technology to prolong the life of blood platelets. This technology is so important, it will touch everyone's life on earth. Currently millions of people undergo cancer treatment each year, which causes damage to blood platelets resulting in a longer recovery time.

HBSC's proprietary technology to prolong the platelets will allow for a larger and healthier inventory of blood which will help millions of people. Blood platelets are highly susceptible to bacterial contamination, the Food and Drug Administration (FDA) mandates a 5 day shelf life. As a result an estimated $700 million in blood platelets must be discarded every year.

A longer preservation time will allow blood centers and hospitals to cover up to 90% of lost revenues.

HBSC's goal is to prolong the life of blood platelets from the standard 5 days to a period of 7-14 days or longer. This will be a huge medical breakthrough, and I believe it will change human history as we know it.

Currently there are over 82,000 people on the transplant waiting list in the US alone. Organs can only be preserved for a very brief period of time ranging from hours to a maximum of 36 hours. HBSC believes their technology will extend this period to days!!! By extending organ preservation time, transplant recipients can expect optimized transplant success since more time is available for organs to be more suitably matched and thereby lessening the immune response.

In a recent press release, HBSC's testing shows that the animal kidneys exhibited a survival rate of 80% compared to a 10% survival rate using the current European standard. Dr. David Winter, HBSC's President, concluded by stating "If we can achieve similar results with human kidneys, the ability to store and preserve kidneys for longer periods of time before transplantation provides a better donor to recipient matching of the organ.

Make sure you read over HBSC's website to learn more about their incredible technology. http://www.humanbiosystems.com

Make sure HBSC is on your watch list, this could be a biotech leader in the making.

Recent News:

HUMAN BIOSYSTEMS INC Files SEC form 8-K, Entry into Material Agreement, Financial Obligation Matter, Sale of Equity
EDGAR Online (Tue, Mar 14)
Breaking News: Human BioSystems Corroborates Organ Preservation Survival Study Results With Functional Biochemical Marker Testing
Business Wire (Tue, Feb 21)
HUMAN BIOSYSTEMS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Mon, Jan 23)
Human BioSystems Reviews Major Events In Year 2005-CEO Interviewed by Wall Street Reporter
Business Wire (Mon, Jan 23)
Breaking News: Human BioSystems Continues Platelet Testing at Second Independent Laboratory
Business Wire (Wed, Jan 11)